Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Tremor tracks 3 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • CRBPCorbus Pharmaceuticals Inc.
    0Calm

    A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

    Signing up patientsPhase 3260 patientsMain results: Dec 2027
  • CRBPCorbus Pharmaceuticals Inc.
    0Calm

    A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

    Signing up patientsPhase 1/2348 patientsMain results: Jan 16, 2027
  • CRBPCorbus Pharmaceuticals Inc.
    0Calm

    First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

    Signing up patientsPhase 1/2156 patientsMain results: Nov 1, 2026

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

7 sales (1 not pre-planned) · 3 purchases

  • Cormorant Asset Management, LPLarge shareholder · Oct 29, 2026Sold 425,000 sharesabout $1.7 million · not pre-planned
  • Ben YongBoard member · Sep 14, 2026Sold 2,000 sharesabout $16 thousand · pre-planned
  • Saxena Nishant CChief Business Officer · Aug 11, 2026Bought 2,600 sharesabout $25 thousand ·
  • Cohen YuvalChief Executive Officer · Aug 7, 2026Sold 17,000 sharesabout $171 thousand · pre-planned
  • Moran Sean F.Chief Financial Officer · Aug 7, 2026Sold 12,000 sharesabout $121 thousand · pre-planned
  • Kung WinstonBoard member · Jun 10, 2026

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Shared information with investorsNews report (8-K)Oct 15, 2026
  • Shared information with investors; Other newsNews report (8-K)Sep 14, 2026
  • New shares being soldNew shares being sold (424B5)Aug 7, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 6, 2026
  • Shared quarterly results; Shared information with investorsNews report (8-K)Aug 6, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Sold 2,026 sharesabout $16 thousand · pre-planned
  • Altmeyer AnneBoard member · Jun 10, 2026Sold 2,412 sharesabout $19 thousand · pre-planned
  • Jenkins John KennethBoard member · Jun 10, 2026Sold 4,800 sharesabout $38 thousand · pre-planned
  • Saxena Nishant CChief Business Officer · Jun 3, 2026Bought 9,000 sharesabout $68 thousand ·
  • Saxena Nishant CChief Business Officer · Jun 2, 2026Bought 4,500 sharesabout $33 thousand ·
    • Signed a major agreement; Shared information with investorsNews report (8-K)
    Jul 6, 2026
  • Shared information with investors; Other newsNews report (8-K)May 26, 2026
  • Signed a major agreement; An executive or board member joined or left; Shared information with investorsNews report (8-K)May 21, 2026
  • An executive or board member joined or left; Shared information with investorsNews report (8-K)May 14, 2026
  • Quarterly reportQuarterly report (10-Q)May 12, 2026
  • Shared quarterly results; Shared information with investorsNews report (8-K)May 12, 2026